Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 08/03/17
Due: 08/03/18
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 05/31/15
Due: 05/31/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant | NCT00737113 | Mitchell Horwitz, MD | user2@example.com | None | 2008-09-30 | 2013-12-31 | 2014-12-31 | - | - | 2025-07-14 |
| Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant | NCT01627275 | Mitchell Horwitz, MD | user2@example.com | None | 2012-06-30 | 2017-08-03 | 2018-08-03 | - | - | 2025-07-14 |
| Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant | NCT01280955 | Mitchell Horwitz, MD | user2@example.com | None | 2011-12-31 | 2015-05-31 | 2016-05-31 | - | - | 2025-07-14 |